If this is what the secret squirrel stuff some were going on about earlier in the week, it is a bit of a fizzer .... good to see the patent granted but realistically it is not like it wasn't expected ? I mean who else were they going to award the patent to for DEP® cabazitaxel ?
It's not like Sanofi could dispute it as they don't own the DEP technology and let's face it, Starpharma didn't even nominate the announcement as price sensitive for the reasons I have outlined above
I guess we will see if Sanofi are interested enough in it to sign a deal whenever the trials finish next year (or the year after knowing SPL)... we all know how DEP® Remdesivir went - JF is still waiting for Gilead to return her call IMO ?
Ann: US patent issued for DEP cabazitaxel nanoparticle, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $24.53K | 250.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 199586 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 173425 | 2 |
View Market Depth
| Last trade - 12.14pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |